United Kingdom Infectious Diagnostics Market Outlook to 2021
Summary
GlobalDatas new report, "United Kingdom Infectious Diagnostics Market Outlook to 2021", provides key market data on the United Kingdom Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the United Kingdom Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Infectious Diagnostics Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Infectious Diagnostics Market, United Kingdom 7
3.1 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2007-2014 7
3.2 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2014-2021 9
3.2.1 Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 11
3.2.2 Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 13
3.3 Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 15
3.4 Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2014 16
4 Overview of Key Companies in United Kingdom, Infectious Diagnostics Market 18
4.1 F. Hoffmann-La Roche Ltd. 18
4.1.1 Company Overview 18
4.2 Abbott Laboratories 18
4.2.1 Company Overview 18
4.3 Siemens Healthcare 18
4.3.1 Company Overview 18
4.4 Danaher Corporation 19
4.4.1 Company Overview 19
4.5 Becton, Dickinson and Company 19
4.5.1 Company Overview 19
4.6 Alere Inc. 19
4.6.1 Company Overview 19
4.7 Bio-Rad Laboratories, Inc. 20
4.7.1 Company Overview 20
5 Infectious Diagnostics Market Pipeline Products 21
6 Financial Deals Landscape 33
6.1 Partnerships 33
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 33
6.1.2 Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 34
6.2 Venture Financing 35
6.2.1 Atlas Genetics Raises USD20 Million in Series C Financing 35
7 Appendix 37
7.1 Research Methodology 38
7.1.1 Coverage 38
7.1.2 Secondary Research 38
7.1.3 Primary Research 38
7.1.4 Company Share Analysis 39
7.1.5 Distribution Share Analysis 39
7.2 GlobalData Consulting 39
7.3 Contact Us 39
7.4 Disclaimer 40
List Of Tables
1.1 List of Tables
Table 1: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 12
Table 4: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Table 5: Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 15
Table 6: Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 17
Table 7: Infectious Diagnostics Market Pipeline Products 21
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 33
Table 9: Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 34
Table 10: Atlas Genetics Raises USD20 Million in Series C Financing 35
List Of Figures
1.2 List of Figures
Figure 1: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 11
Figure 4: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Figure 5: Infectious Diagnostics Market, United Kingdom, Company Share (%) 2014 16
